Home/Filings/4/0001415889-24-030071
4//SEC Filing

Jin David 4

Accession 0001415889-24-030071

CIK 0001429260other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 4:30 PM ET

Size

5.5 KB

Accession

0001415889-24-030071

Insider Transaction Report

Form 4
Period: 2024-12-19
Jin David
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.001

    2024-12-19+1,000,0001,240,893 total
Footnotes (2)
  • [F1]Represents an award of 1,000,000 restricted stock units which will vest in 16 equal quarterly installments beginning after December 20, 2024. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Corporate Transaction (as defined in the Fortress Biotech, Inc. 2013 Stock Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.
  • [F2]Total holdings include 1,230,000 shares underlying deferred restricted stock units.

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeother

Related Parties

1
  • filerCIK 0001930732

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:30 PM ET
Size
5.5 KB